CardioGenics Stock Price, News & Analysis (OTCMKTS:CGNH)

$0.01 -0.01 (-52.15 %)
(As of 02/20/2018 10:32 AM ET)
Previous Close$0.02
Today's Range$0.01 - $0.01
52-Week Range$0.00 - $0.03
Volume4,500 shs
Average Volume265,727 shs
Market Capitalization$2.01 million
P/E RatioN/A
Dividend YieldN/A
Beta0.57

About CardioGenics (OTCMKTS:CGNH)

CardioGenics Holdings Inc. is engaged in business of development of products targeting the immunoassay segment of the point-of-care in vitro diagnostic (IVD) testing market. The Company is engaged in development of technology and products, which include The QL Care Analyzer (QLCA), Cardiovascular Tests and Paramagnetic beads. The QLCA is a point-of-care (POC) immunoassay analyzer. The QLCA uses a self-metering cartridge to perform immunoassay tests at the POC. To support the use of the QLCA, the Company develops approximately four immunoassay tests designed to identify cardiac markers in the blood at the time of a heart attack. Its immunoassay tests include Troponin I (TnI), Plasminogen Activator Inhibitor Type-1 (PAI-1), Heart Failure Risk Stratification (HFRS) and Heart Failure Genomics Risk (HFGR). The Company's TnI test product is in the pilot testing phase. Paramagnetic (magnetic) beads are the solid phase employed during immunoassays tests.

Receive CGNH News and Ratings via Email

Sign-up to receive the latest news and ratings for CGNH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:CGNH
CUSIPN/A
Phone905-673-8501

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares96,050,000

CardioGenics (OTCMKTS:CGNH) Frequently Asked Questions

What is CardioGenics' stock symbol?

CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH."

Who are some of CardioGenics' key competitors?

Who are CardioGenics' key executives?

CardioGenics' management team includes the folowing people:

  • J. Neil Tabatznik, Director/Acting Chairman (Age 66)
  • Yahia Gawad M.D., Director & Chief Executive Officer (Age 58)
  • James A. Essex, Chief Financial Officer (Age 68)
  • Linda J. Sterling, Corporate Secretary, Director (Age 55)
  • Karim J. Murabet, Independent Director (Age 58)

How do I buy CardioGenics stock?

Shares of CardioGenics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CardioGenics' stock price today?

One share of CardioGenics stock can currently be purchased for approximately $0.01.

How big of a company is CardioGenics?

CardioGenics has a market capitalization of $2.01 million.

How can I contact CardioGenics?

CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The company can be reached via phone at 905-673-8501 or via email at [email protected]


MarketBeat Community Rating for CardioGenics (CGNH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  23 (Vote Outperform)
Underperform Votes:  25 (Vote Underperform)
Total Votes:  48
MarketBeat's community ratings are surveys of what our community members think about CardioGenics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CardioGenics (OTCMKTS:CGNH) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

CardioGenics (OTCMKTS:CGNH) Earnings History and Estimates Chart

Earnings by Quarter for CardioGenics (OTCMKTS:CGNH)

CardioGenics (OTCMKTS CGNH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/23/2015Q3 2015($0.01)ViewN/AView Earnings Details
1/31/2012Q4 2011($0.01)($0.01)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

CardioGenics (OTCMKTS:CGNH) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for CardioGenics (OTCMKTS:CGNH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

CardioGenics (OTCMKTS CGNH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 41.40%
Insider Trades by Quarter for CardioGenics (OTCMKTS:CGNH)

CardioGenics (OTCMKTS CGNH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/5/2015J Neil TabatznikDirectorBuy959,039$0.11$105,494.29View SEC Filing  
2/5/2015James EssexCFOBuy461,575$0.11$50,773.25View SEC Filing  
2/5/2015Linda J SterlingInsiderBuy281,162$0.11$30,927.82View SEC Filing  
2/5/2015Yahia GawadCEOBuy1,896,246$0.11$208,587.06View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

CardioGenics (OTCMKTS CGNH) News Headlines

Source:

SEC Filings

CardioGenics (OTCMKTS:CGNH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

CardioGenics (OTCMKTS:CGNH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

CardioGenics (OTCMKTS CGNH) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.